India markets open in 3 hours 49 minutes

Cipla Limited (CIPLA.BO)

BSE - BSE Real Time Price. Currency in INR
Add to watchlist
957.80+2.15 (+0.22%)
At close: 3:56PM IST
Full screen
Previous close955.65
Bid0.00 x 0
Ask957.80 x 0
Day's range954.50 - 965.80
52-week range356.75 - 965.80
Avg. volume204,378
Market cap772.337B
Beta (5Y monthly)N/A
PE ratio (TTM)46.97
Earnings date06-Aug-2019 - 10-Aug-2019
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PTI

    Cipla gets USFDA nod for inhalation product

    New Delhi, Jun 23 (PTI) Drug major Cipla on Wednesday said it has received final approval from the US health regulator for Arformoterol Tartrate Inhalation Solution, used to treat conditions like chronic bronchitis and emphysema, in the US market.

  • PTI

    Avenue Therapeutics gets second complete response letter from USFDA for intravenous tramadol

    New Delhi, Jun 15 (PTI) Drug firm Cipla on Tuesday said its step-down associate firm Avenue Therapeutics Inc has received a second complete response letter (CRL) from the US health regulator for its new drug application for intravenous tramadol.

  • PTI

    Business highlights

    New Delhi, June 1 (PTI) Following are the top business stories at 1940 hours: DEL21 BIZ-MOODYS LD-INDIA-GDP Indian economy to grow 9.3 pc in FY22, 2nd COVID wave raises risks to credit profile: Moody's New Delhi: Indian economy would rebound in the current fiscal ending March 2022 and clock a growth of 9.3 per cent, but a severe second COVID wave has increased risks to India's credit profile and rated entities, Moody's Investors Service said on Tuesday.